Science ❯ Biotechnology ❯ Vaccine Development

Clinical Trials

mRNA Technology H5N1 Vaccine mRNA Vaccine Trials Phase II Trials Regulatory Affairs mRNA Vaccines Efficacy Studies Safety Protocols mRNA Therapies Immunology Safety Concerns Research Studies Phase 1 Trials Phase 3 Trials Phase 3 Studies Approval Processes

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

An unexpected rate of hives in participants has prompted vaccine tweaks ahead of larger trials.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2026 Mina Labs Inc.